Related references
Note: Only part of the references are listed.Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes
Makoto Hirao et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2007)
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation
Rutger L. van Bezooijen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function
Shelly R. Peyton et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism
Jian Q. Feng et al.
NATURE GENETICS (2006)
E11/gp38 selective expression in osteocytes: Regulation by mechanical strain and role in dendrite elongation
Keqin Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Intrinsic mechanical properties of the extracellular matrix affect the behavior of pre-osteoblastic MC3T3-E1 cells
CB Khatiwala et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
RL Bezooijen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
The histochemical and cytochemical changes from formative to resorptive osteocytes
K Irie et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2000)